| 000 | 04375cam a2200409Mi 4500 | ||
|---|---|---|---|
| 001 | 94826 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102112633.0 | ||
| 006 | m o d | ||
| 007 | cr |n|---aucuu | ||
| 008 | 161105t20162017sz o 001 0 eng d | ||
| 020 |
_a3319416774 _q(electronic bk.) |
||
| 020 |
_a9783319416779 _q(electronic bk.) |
||
| 020 | _z3319416758 | ||
| 020 | _z9783319416755 | ||
| 035 |
_a(OCoLC)962154517 _z(OCoLC)961910183 _z(OCoLC)962017211 |
||
| 040 |
_aEBLCP _cEBLCP _dOCLCO _dN$T _dYDX _dGW5XE _dIDEBK _dN$T _dOCLCQ _dOCLCF _dUAB _dIOG _dMERER _dESU _dOCLCQ _dJBG _dIAD _dICN _dOTZ _dOCLCQ _dU3W _dES-MaUEC _bspa |
||
| 050 | 4 |
_aRC268.4 _b2017 EB |
|
| 245 | 0 | 0 |
_aAdipocytokines, energy balance, and cancer _cOfer Reizes, Nathan A. Berger, editors. |
| 264 | 1 |
_aCham, Switzerland _bSpringer International Publishing |
|
| 300 | _a1 recurso en línea (306 páginas) | ||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 490 | 0 |
_aEnergy Balance and Cancer _vv. 12 |
|
| 505 | 0 | _aPreface; Contents; Contributors; Chapter 1: Adipocytes, Adipocytokines, and€Cancer; Adipose Tissue; Adipocytokines and€Cancer; Leptin; Adiponectin; Visfatin; Resistin; Apelin; Chemerin; Omentin; Nesfatin; Vaspin; Retinol-Binding Protein-4; Cytokines; Adipocytes and Tumor Metabolism; Conclusion; References; Chapter 2: Adiponectin, Obesity, and€Cancer; Introduction; Adiponectin; Adiponectin Isoforms: Structural Considerations; Adiponectin Receptors; Adiponectin Modifications: Implication for€Cancer; Adiponectin Signaling Pathways Related to€Cancer. | |
| 505 | 8 | _aActivation of€Adiponectin as€an€Indirect Strategy to€Inhibit Leptin Conclusion; References; Chapter 5: Retinol Binding Protein 4: Role in€Diabetes and€Cancer; Vitamin A: Absorption and€Metabolism; Retinoid-Binding Proteins; RBP4 and€Transport of€Retinol in€the€Circulation; Cellular Retinol-Binding Proteins; Vitamin A Uptake by Extrahepatic Tissues: RBP4 and€STRA6; RBP4 Level Is Correlated with€Obesity and€Insulin Resistance; RBP4 and€STRA6 in€Insulin Resistance: A€Mechanism of€Action; Alternative Models for€Understanding How RBP4 Induces Insulin Resistance. | |
| 505 | 8 | _aConnection Between Dysregulated Leptin Levels and€Cancer Effect of€Leptin on€Cancer Progression and€Metastasis; Leptin as€a€Regulator or an€Important Participant of€Various Oncogenic Pathways; Canonical Signaling Pathways of€Leptin; Noncanonical Signaling-Functional Interactions of€Leptin with€Multiple Pathways; Leptin, Estrogen, and€Aromatase; Leptin, IGF1, Insulin, and€EGFR; Leptin, Notch, and€Wnt/Catenin Pathway; Strategies to€Inhibit Leptin Signaling; Direct Inhibition of€Leptin Signaling Using Small Molecule Inhibitors. | |
| 505 | 8 | _aPreclinical Rodent Studies Evaluating Leptin's Effects on€Mammary Tumor Development/Progression Leptin/Adiponectin Ratio; Leptin Antagonists; Leptin Advances Malignancy in€Tumor Cells via€Additional Intrinsic Mechanisms; Leptin Effects on€the€Tumor Microenvironment also Contributes to€Tumor Progression; Leptin's Role in€Inflammation, Chemotaxis, and€Adaptive Immunity Impacts the€Cancer Host's Immune Responses; Leptin and Non-breast Malignancies; Conclusions; References; Chapter 4: Leptin-Signaling Pathways as€Therapeutic Targets in€Cancer. | |
| 505 | 8 | _aRole of€Adiponectin in Tumor Initiation and€Progression Types of€Cancer Associated with€Obesity and€Decreased Adiponectin; Colorectal Cancer; Endometrial Cancer; Prostate Cancer; Breast Cancer; Gastric Cancer; Hematological Malignancies; The L/A Ratio; Adiponectin Chemopreventatives; Concluding Remarks; References; Chapter 3: Leptin in€Cancer: Epidemiology and Mechanisms; An Overview of€the€Early Studies of€Leptin and Breast Cancer; Epidemiological Studies of€Leptin and€Breast Cancer; Recent In Vitro Studies. | |
| 650 | 7 |
_9667182 _aTejido adiposo _2fast _0(OCoLC)fst00796650 _0 |
|
| 700 | 1 |
_aBerger, Nathan A. _984721 |
|
| 700 | 1 | _aReizes, Ofer. | |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-41677-9 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 988 | _aSpringer_Medicine_2017 | ||
| 998 |
_b02/2018 _dz _e- _zSI |
||
| 999 |
_c94826 _d94826 _x1 |
||